WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001001984) LEVODOPA / CARBIDOPA / ENTACAPONE PHARMACEUTICAL PREPARATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/001984    International Application No.:    PCT/FI2000/000593
Publication Date: 11.01.2001 International Filing Date: 29.06.2000
Chapter 2 Demand Filed:    11.12.2000    
IPC:
A61K 9/20 (2006.01), A61K 31/275 (2006.01)
Applicants: ORION CORPORATION [FI/FI]; Orionintie 1, FIN-02200 Espoo (FI) (For All Designated States Except US).
KALLIOINEN, Sari [FI/FI]; (FI) (For US Only).
KERVINEN, Lasse [FI/FI]; (FI) (For US Only).
LAAKSONEN, Marja [FI/FI]; (FI) (For US Only).
LINTULAAKSO, Jarmo [FI/FI]; (FI) (For US Only).
NISKANEN, Mervi [FI/FI]; (FI) (For US Only).
PARTANEN, Marja [FI/FI]; (FI) (For US Only).
RITALA, Marja [FI/FI]; (FI) (For US Only).
VAHERVUO, Kari [FI/FI]; (FI) (For US Only).
VIRKKI, Matti [FI/FI]; (FI) (For US Only)
Inventors: KALLIOINEN, Sari; (FI).
KERVINEN, Lasse; (FI).
LAAKSONEN, Marja; (FI).
LINTULAAKSO, Jarmo; (FI).
NISKANEN, Mervi; (FI).
PARTANEN, Marja; (FI).
RITALA, Marja; (FI).
VAHERVUO, Kari; (FI).
VIRKKI, Matti; (FI)
Agent: ORION CORPORATION; Orion Pharma, Industrial Property Rights, P.O. Box 65, FIN-02101 Espoo (FI)
Priority Data:
991485 30.06.1999 FI
Title (EN) LEVODOPA / CARBIDOPA / ENTACAPONE PHARMACEUTICAL PREPARATION
(FR) PREPARATION PHARMACEUTIQUE A BASE DE LEVODOPA/CARBIDOPA/ENTACAPONE
Abstract: front page image
(EN)The invention relates to an oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or a pharmaceutically acceptable salt or hydrate thereof, and comprising at least one pharmaceutically acceptable excipient. The composition of the invention can be used e.g. for the treatment of Parkinson's disease.
(FR)L'invention concerne une composition orale, solide, à dose fixe, comprenant des doses efficaces sur le plan pharmacologique d'entacapone, lévodopa et carbidopa; elle concerne également un sel ou hydrate de ces substances, de même qu'au moins un excipient acceptable sur le plan pharmaceutique. On peut utiliser la composition de l'invention, par exemple dans le traitement de la maladie de Parkinson.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)